Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

Integritas Communications

Value-Based HIV Formularies: Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Access Activity

Overview / Abstract:

Over the last 3 decades, ongoing advances in antiretroviral therapy (ART) for patients infected with human immunodeficiency virus (HIV) have improved outcomes across a diverse range of cohorts and clinical circumstances .1,2 As new data comparing existing drug regimens are published and new medications become available, HIV formularies must be periodically reviewed and adjusted to reflect both the evolving clinical evidence and various nonclinical parameters.3 Broad-based pharmacoeconomic assessment strategies should be used to optimize pharmacy-management practices within a value-based paradigm.4,5 In recognition of the needs of a multidisciplinary audience of HIV-formulary decision-makers, this webinar will bring together an expert faculty panel to review the latest clinical evidence for ART, available pharmacoeconomic data and their associated analytic instruments, and other key factors that can influence formulary changes and healthcare utilization. With an overall goal of improving HIV formularies, this educational program will help learners understand and address the complex relationships among healthcare cost, quality, and utilization.

References
1. Jones J, et al. CROI 2017: Advances in antiretroviral therapy. Top Antivir Med. 2017;25(2): 51-67.
2. DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed September 29, 2017.
3. Vogenberg FR et al. Systemic market and organizational changes: Impact on P&T committees. P & T 2017;42(1):28-32.
4. Fischer KE, et al. Link between process and appraisal in coverage decisions: An analysis with structural equation modeling. Med Decis Making. 2013;33(8):1009-1025.
5. Malone DC. The role of pharmacoeconomic modeling in evidence-based and value-based formulary guidelines. J Manag Care Pharm. 2005;11(4 Suppl):S7-S10.

Expiration

Apr 27, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

1.0

Accreditation

ACCME, ACPE, CE

Presenters / Authors / Faculty

Richard A. Elion, MD; James A. Jorgenson, RPh, MS, FASHP; Robert LoNigro, MD, MS

Sponsors / Supporters / Grant Providers

This activity is supported by an unrestricted educational grant from Viiv Healthcare and jointly provided by Integritas Communications, Specialty Healthcare Benefits Council (SHBC) and Purdue University College of Pharmacy.

Keywords / Search Terms

Integritas Communications Continuing Medical Education, CME, Continuing Education, CE, Pharmacy credit, ACPE, HIV, human immunodeficiency virus, Elion, Jorgenson, LoNigro, antiretroviral therapy, ART, Free CME, Free CE, Free ACPE, Free Pharmacy Credit, video, webcast Free CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.